Pediatrics Doctors in Vermont Medicare Details, Address, Contact

216 Pediatrics doctors found. Showing 141 - 160

Whitney Jeanne Washburn Sevey, Pediatrics Medicare: Medicare Enrolled Practice Location: 11 Haydenberry Dr Unit 103, Milton, VT 05468 Phone: 802-893-1200    Fax: 802-893-2756

Joseph D Nasca, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 789b Ethan Allen Hwy, Milton, VT 05468 Phone: 802-527-2237    Fax: 802-527-2267

Dr. Thomas G Bolduc, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11 Haydenberry Dr Unit 103, Milton, VT 05468 Phone: 802-893-1200

Mr. Scott Jason Cohen, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11 Haydenberry Dr Unit 103, Milton, VT 05468 Phone: 802-893-1200    Fax: 802-893-2756

Kristen Van Woert Connolly, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11 Haydenberry Dr Ste 41, Milton, VT 05468 Phone: 802-893-1200    Fax: 802-893-2756

Dr. Michael Edward Visker, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 927 Ethan Allen Hwy Unit 1, Milton, VT 05468 Phone: 802-527-2237

Colleen Carroll Moran, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 609 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-7337    Fax: 802-888-7398

Dr. Sarayu Balu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 609 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-7337    Fax: 802-888-7398

Dr. Thomas Addis Emmet Moseley Iii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 121 Medical Village Dr, Newport Pediatrics And Adolescent Medicine Pllc, Newport, VT 05855 Phone: 802-334-5929

Dr. Alexandra Bannach, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 121 Medical Village Dr, Newport, VT 05855 Phone: 802-334-5929    Fax: 802-487-1051

Sarah L Mcauliff, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 121 Medical Village Dr, Newport, VT 05855 Phone: 802-334-5929

Dr. John M. Saroyan, M.D. Pediatrics - Hospice and Palliative Medicine Medicare: Medicare Enrolled Practice Location: 316 Main St, Norwich, VT 05055 Phone: 802-526-2380    Fax: 802-526-2518

Joseph C Pelletier, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2420    Fax: 802-728-2394

Devin Alexander, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2420

Louis A. Dinicola, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2420    Fax: 802-728-2613

Elizabeth H. Jewett, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2420    Fax: 802-728-2613

Dr. Alyssa Katherine Parker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12 Burnett Ct, Richmond, VT 05477 Phone: 802-434-5090

Helen Schottel, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12 Burnett Ct, Richmond, VT 05477 Phone: 802-434-5090

Dr. Paul J. Parker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12 Burnett Ct, Richmond, VT 05477 Phone: 802-434-5090    Fax: 802-329-2144

Judy A. Nelson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 General Wing Rd, Rutland, VT 05701 Phone: 802-773-9131    Fax: 802-775-6141

News Archive

Upsher-Smith initiates USL261 ARTEMIS1 Phase III study for seizure clusters in epilepsy patients

Upsher-Smith Laboratories, Inc. announced today the initiation of a Phase III clinical trial to evaluate the safety and efficacy of USL261, an investigational intranasal midazolam, for the rescue treatment of seizures in patients on stable anti-epileptic drug (AED) regimens who require control of intermittent bouts of increased seizure activity, frequently referred to as seizure clusters. USL261 has been granted orphan drug designation for this use by the Food and Drug Administration (FDA).

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

In June, two studies in Science reported an antibody cocktail against SARS-CoV-2 developed from studies in humanized mice and recovering patients. The two antibody cocktail was designed to bind the virus to reduce the risk of a drug-resistant form emerging.

Inspire's denufosol tetrasodium TIGER-1 Phase 3 trial for CF published in AJRCCM

Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.

Astellas Pharma, OSIP enter into confidentiality agreement

Astellas Pharma Inc. confirmed today that it has entered into a confidentiality agreement with OSI Pharmaceuticals, Inc. Under the agreement, OSI will provide Astellas with access to certain non-public information. This follows Astellas' approach to OSI after OSI's announcement that its board of directors had instructed its management and financial advisors to contact interested third parties regarding a potential transaction.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8(current)
• 9
• 10
• 11